Article Versions Notes

Bürdek M, Prinz PU, Mutze K, Tippmer S, Geiger C, Longinotti G, Schendel DJ. Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies. Cancers. 2025; 17(2):242. https://doi.org/10.3390/cancers17020242

Bürdek, Maja, Petra U. Prinz, Kathrin Mutze, Stefanie Tippmer, Christiane Geiger, Giulia Longinotti, and Dolores J. Schendel. 2025. "Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies" Cancers 17, no. 2: 242. https://doi.org/10.3390/cancers17020242

Bürdek, M., Prinz, P. U., Mutze, K., Tippmer, S., Geiger, C., Longinotti, G., & Schendel, D. J. (2025). Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies. Cancers, 17(2), 242. https://doi.org/10.3390/cancers17020242